HomeNewscoronavirusOver 40 lakh children get COVID-19 vaccine on first day; Parents say it is a big relief

Over 40 lakh children get COVID-19 vaccine on first day; Parents say it is a big relief

''Congrats to all my young friends between the age group of 15-18 who got vaccinated. Congrats to their parents as well. I would urge more youngsters to get vaccinated in the coming days!", PM Modi tweeted.

January 03, 2022 / 22:06 IST
Story continues below Advertisement
Girls gesture after receiving a dose of Bharat Biotech's COVID-19 vaccine, Covaxin, during a vaccination drive for children aged 15-18 in Mumbai, India, January 3, 2022. (Image: Reuters)
Girls gesture after receiving a dose of Bharat Biotech's COVID-19 vaccine, Covaxin, during a vaccination drive for children aged 15-18 in Mumbai, India, January 3, 2022. (Image: Reuters)

As India launched a COVID-19 vaccination drive for the 15-18 age group on Monday, over 40 lakh children received their first dose with many of the beneficiaries and their parents saying they feel a sense of relief, especially in the backdrop of the fresh rise in cases.

From setting up attractive selfie points to putting up imaginative posters and colourful balloons, the designated vaccination centres, mostly schools and educational institutes, were decked up to welcome the youngsters. The children, some dressed in school uniforms and others in casuals, were greeted with flowers and were gifted pens and eatables at some places after receiving the vaccine.

Story continues below Advertisement

"Well done Young India! "Over 40 Lakhs between 15-18 age group received their first dose of #COVID19 vaccine on the 1st day of vaccination drive for children, till 8 PM. This is another feather in the cap of India's vaccination drive," Union Health Minister Mansukh Mandaviya said in a tweet.

Follow all live updates on Coronavirus Omicron here

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show